Cowen Reiterates Outperform Rating on Boston Scientific (BSX) Following TCT Event
Tweet Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $50.00 price target on Boston Scientific (NYSE: BSX) following the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
